| Predicate |
Object |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
1997-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3207861758cb0ac7908d9d785d3cbef2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06187c775162b2fdd03db06b3617b360
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57955c5cd279a69079a56a34c7ef8cc4 |
| publicationDate |
2000-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-9903165-A2 |
| titleOfInvention |
The use of amosulalol in the manufacture of a medicament for the treatment of circulatory disorders of the eye |
| abstract |
The present invention relates to the use of 5- [1-hydroxy-2- (2-methoxyphenoxy) ethylamine] ethyl] 2-methylbenzylfiltamide or as an acid addition salting agent for the preparation of a medicament for the treatment of circulatory disorders of the eye. ŕ |
| priorityDate |
1997-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |